Menu
Washingtoner
  • Home
  • Health
  • Artificial Intelligence
  • Technology
  • Entertainment
  • Real Estate
  • Non-profit
  • Business
  • Concealed Carry
Washingtoner

Study Finds Lotus Vaping Technologies' Flavored E-Liquids Reduce Smokers' Cigarettes Per Day at Significantly Higher Rate Than Tobacco Flavor
Washingtoner/10239600

Trending...
  • Final Week to Register for Free Spokane Community Conference
  • Renkeer Water Quality Sensors Support Efficient Operation of AI Liquid Cooling Systems
  • Author Robert A. Robinson Introduces Anarchy at the AYP:
A rigorous three-month longitudinal cohort study of several of flavored bottled e-liquids demonstrated that those flavors were significantly more effective at reducing cigarettes smoked per day than tobacco-flavored e-liquids.

BOISE, Idaho - Washingtoner -- Lotus Vaping Technologies, LLC, a Boise, Idaho-based manufacturer of bottled e-liquids for use in electronic nicotine delivery systems ("ENDS") or e-cigarettes, announced today that a rigorous three-month longitudinal cohort study of several of its FreenomsTM branded flavored bottled e-liquids demonstrated that those flavors were significantly more effective at reducing cigarettes smoked per day than tobacco-flavored e-liquids.

The three-month study conducted from March 2023 to August 2023 involved 451 randomly assigned participants who were cigarette smokers, 221 of which were assigned to a control group that used only tobacco-flavored e-liquid, and 230 of which were assigned to a group that could use any of five different non-tobacco flavored bottled e-liquids, including Lotus's proprietary BluenomenomTM, StranomenonTM, X2 Cactus Jackfruit, and White Peach Raspberry flavors.

More on Washingtoner
  • Navigating a Changing Market: How AIX Group Is Responding to a Challenging Year
  • 450 Million Revenue Run Rate, Global Telecom Reach and a New Digital Growth Opportunity Take Center Stage: IQSTEL, Inc. (N A S D A Q: IQST)
  • Wave Helicopters Takes FLIBS 2026 to New Heights
  • Canada's First Data Lakehouse Goes Global in Banking: Nabil Bank Becomes Nepal's First Bank to Implement a True Agentic Lakehouse Platform, DataNature
  • Latin GRAMMY-Winning Cuban-American Conductor Dr Yalil Guerra to Lead Pepperdine's Oklahoma!

At the end of three months, the average number of cigarettes smoked per day ("CPD") by the tobacco-flavored control group was reduced from 12.51 to 9.54, for a 23.72% reduction, while for the flavored e-liquid group, the average CPD was reduced from 11.70 to 6.88, for a 41.25% reduction.  The reduction in cigarettes smoked per day was thus 73.9% greater for the flavored group than the tobacco-flavored group. The study results also demonstrated statistically significant differences between several of Lotus's flavored e-liquids when compared head-to-head against tobacco-flavored e-liquids with respect to CPD reduction.

Additionally, a full 14.3% of study participants in the flavored group had quit smoking cigarettes altogether by the end of the third month—a rate that is substantially higher than that typically reported for FDA-approved nicotine replacement therapy products (9.0%).

Lotus's Director of Sales, Mike Larsen stated, "We are very excited about these study results. This study demonstrates what users of our products have known anecdotally for a long time—flavored e-liquids are more effective than tobacco flavor at promoting cigarette smoking reduction and cessation. The FDA has been asking for this data—we hope it will now take it into consideration when reviewing our premarket tobacco product applications and grant our flavored products the marketing authorizations that they deserve."

More on Washingtoner
  • Highsfield Showcases Earth Zoom Generator for Cinematic AI Videos
  • Patton AI Launches Patton Hive 4.5: Wartime Breakthroughs for Drones and Robots When GPS Goes Dark
  • Wisdom trumps wrinkles: 66% of Aussie women wouldn't turn back the clock
  • Attorney Jason M. Sullivan Quoted in The Telegraph on Trump's $10 Billion BBC Lawsuit
  • Community Members and Stakeholders Invited to Help Shape a More Accessible Tacoma

About Lotus Vaping Technologies, LLC – Creator of NomenonsTM E-Liquids

Established in 2013, Lotus is a leading manufacturer and wholesaler of premium e-liquids in the United States providing a diverse range of vapor products for sale to adult consumers that satisfy a wide variety of consumer preferences and serve as alternatives to combustible cigarettes. Lotus is committed to responsible manufacturing processes and utilizes only the highest standards in its e-liquid production.

Media Contact
Mike Larsen
mike@lotusecigs.com


Source: Lotus Vaping Technologies, LLC
Filed Under: Health

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • Heritage at Manalapan Announces Limited-Time Mortgage Rate Buydown on Select Quick Move-In Homes
  • Good Organics Now at Pop Up Grocer NYC With October 30 Sampling Event
  • KeysCaribbean Announces Temporarily Reduced Rates At Village at Hawks Cay Villas
  • Commercial Manufacturing Validation Completed as November 10 FDA Milestone Approaches; Critical FDA Milestone Close: NRx Pharmaceuticals NAS DAQ: NRXP
  • Electives Launches "Electives for Everyone," Making Live Expert-Led Learning Available to Every Employee
  • Tax Tops the List as Wealthy Brits Plan Their Exit, La Vida Survey Finds
  • FloorLine Launches Live Shop Floor Tracking for Small Manufacturers
  • "The Tree of Cinema" Installation Brought Film History and Its Audiences Together at TIFF 2026
  • Detroit Lawyer Steals $600,000 Settlement Meant to Protect Child
  • The TOPS Trap: Local AI Models Hallucinated Facts, Cited Real Sources, and Sounded Confident
  • Final Week to Register for Free Spokane Community Conference
  • Heritage at South Brunswick Announces Special Townhome Mortgage Rate Buydown
  • Heritage at Hopewell Announces Limited-Time Mortgage Rate Buydown on Select Quick Move-In Townhomes
  • Air Force Veteran Sean Douglas Delivers Powerful Suicide Prevention Presentations to Hundreds of Marines at Camp Pendleton
  • Breathwork Certification in Seattle, Washington State: First Pacific Northwest Date Set
  • Author Robert A. Robinson Introduces Anarchy at the AYP:
  • Renew Integrative Health Publishes Updated Peptide Therapy Guide to Help Patients Understand Their Options
  • AI Agents Are Getting Their Own Computers. HRTech Leading in Vertical Harness Development
  • UK Financial Ltd Announces Two-for-One Upgrade of Maya 3 to Maya 3G Token Using Chainlink Cross-Chain Technology
  • Critical FDA Milestone much Closer as Preservative-Free Ketamine Review Advances: NRx Pharmaceuticals (N A S D A Q: NRXP)
_catLbl0 _catLbl1

Popular on Washingtoner

  • Spokane: Police Arrest Registered Sex Offender for Child Sexual Abuse Material - 327
  • ResC4EU Final Event at KOMPOZYT-EXPO 2026 – Building Resilient European Supply Chains - 220
  • CinderLabs Launches AI Agent Marketplace: Nine Pre-Built Agents for Regulated Industries - 173
  • Spokane: Convicted Felon Arrested in Vancouver After Eluding SPD Officers - 157
  • City of Spokane to Install First 'Emergency Streets' Lane Closure After Weekend Fatal Crash - 153
  • City of Tacoma Invites Community Members to Share Their Experience Crossing I-5 - 148
  • Spokane: City and Permittable Partner to Support Rebuilding After Wildfires - 130
  • JEGS Launches Transformed Digital Commerce Platform Powered by PhaseZero - 108
  • Tacoma: In-Person Workshop on October 22 for Local Businesses on the City’s Revolving Loan Fund Process
  • Spokane: City to provide asbestos testing, host community resource meetings

Similar on Washingtoner

  • Mr Hospital Bed Cites Hill Rom Hospital Bed Models Best Value Home Care Hospital Beds 2026
  • Hospital Direct Medical Equipment Company Seeing Growth in Used Refurbished Medical Equipment Sales
  • Soft & Sweet Unveils New Studio Location and Website for All-Natural Sugaring in Las Vegas
  • Good Organics Now at Pop Up Grocer NYC With October 30 Sampling Event
  • Commercial Manufacturing Validation Completed as November 10 FDA Milestone Approaches; Critical FDA Milestone Close: NRx Pharmaceuticals NAS DAQ: NRXP
  • Breathwork Certification in Seattle, Washington State: First Pacific Northwest Date Set
  • Renew Integrative Health Publishes Updated Peptide Therapy Guide to Help Patients Understand Their Options
  • Critical FDA Milestone much Closer as Preservative-Free Ketamine Review Advances: NRx Pharmaceuticals (N A S D A Q: NRXP)
  • ClearSight Therapeutics Receives U.S. Patent Notice of Allowance
  • HLN Consulting Names Lilly Kan as Its First Chief Executive Officer
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute